Literature DB >> 19099077

Observation of a dynamic equilibrium between DNA hairpin and duplex forms of covalent adducts of a minor groove binding agent.

Khondaker M Rahman1, Vanelssa Mussa, Mathangi Narayanaswamy, Colin H James, Philip W Howard, David E Thurston.   

Abstract

A dynamic equilibrium between covalent 1:1 hairpin and 2:1 duplex DNA adducts of a pyrrolobenzodiazepine (PBD) minor groove binding agent () has been observed for the first time. The equilibrium, which establishes over 1 hour and must require unfolding of both types of adducts, is surprising given that PBDs normally require DNA minor groove structure for binding and take 24 hours for complete reaction with duplex DNA. The equilibrium is interesting from an energetics perspective due to the well known DNA stabilizing effect of PBDs. This observation could have significance for the in vitro and in vivo biological activity of PBDs, as DNA hairpin and loop structures are known to be important in cellular processes such as transcription and replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19099077     DOI: 10.1039/b816163a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

1.  DNA Sequence Preference and Adduct Orientation of Pyrrolo[2,1-c][1,4]benzodiazepine Antitumor Agents.

Authors:  Khondaker M Rahman; Higia Vassoler; Colin H James; David E Thurston
Journal:  ACS Med Chem Lett       Date:  2010-08-13       Impact factor: 4.345

2.  Effect of base sequence on the DNA cross-linking properties of pyrrolobenzodiazepine (PBD) dimers.

Authors:  Khondaker M Rahman; Colin H James; David E Thurston
Journal:  Nucleic Acids Res       Date:  2011-03-21       Impact factor: 16.971

3.  Pyrrolobenzodiazepines (PBDs) do not bind to DNA G-quadruplexes.

Authors:  Khondaker M Rahman; David B Corcoran; Tam T T Bui; Paul J M Jackson; David E Thurston
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 4.  From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).

Authors:  Julia Mantaj; Paul J M Jackson; Khondaker M Rahman; David E Thurston
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-15       Impact factor: 15.336

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.